1.
Product Overview
2.
Research Methodology
3.
Executive Summary
4.
Voice of Customer
5.
India Animal
Pharmaceuticals Market Outlook, FY2017-FY2027F
5.1.
Market Size & Forecast
5.1.1. By Value &
Volume
5.2.
Market Share & Forecast
5.2.1. By Product Type (Vaccine, Veterinary
Medicine, Others)
5.2.2. By Product
5.2.2.1.
Ectoparasiticides (Ivermectin,
Cypermethrin, Fipronil, Coumaphos, Others)
5.2.2.2.
Endoparasiticides (Ivermectin, Praziquantel, Flubendazole, Milbemycin,
Levamisole, Fenbendazole, Pyrantel, Others)
5.2.2.3.
Anti-Inflammatories (NSAIDs, Corticosteroids,
Others)
5.2.2.4.
Bronchodilators (Theophylline,
Albuterol, Others)
5.2.3. By Animal Type (Companion Animals,
Production Animals)
5.2.4. By Registration (Generic, Patented)
5.2.5. By Region (North, West, South & East)
5.2.6. By Company (FY2021)
5.3. Product Market Map
6. India Vaccine
Product Based Animal Pharmaceutical Market Outlook, FY2017-FY2027F
6.1.
Market Size & Forecast
6.1.1. By Value &
Volume
6.2.
Market Share & Forecast
6.2.1. By Product
6.2.2. By Animal Type
6.2.3. By Registration
7. India Veterinary
Product Based Animal Pharmaceutical Market Outlook, FY2017-FY2027F
7.1.
Market Size & Forecast
7.1.1. By Value &
Volume
7.2.
Market Share & Forecast
7.2.1. By Product
7.2.2. By Animal Type
7.2.3. By Registration
8.
Market Dynamics
8.1.
Drivers
8.2.
Challenges
9.
Market Trends & Developments
10.
Policy & Regulatory Landscape
11.
India Economic Profile
12.
Competitive Landscape
12.1.
Company Profile
12.1.1. Sequent Scientific
Ltd. (Alivira Animal Health Ltd.)
12.1.2. Elanco India Pvt.
Ltd.
12.1.3. Merck Animal Health
India Ltd.
12.1.4. Phibro Animal Health
Corporation
12.1.5. Boehringer Ingelheim
Animal Health
12.1.6. Zoetis India Limited
12.1.7. Virbac Animal Health
India Pvt. Ltd.
12.1.8. Vetoquinol India
Animal Health Pvt. Ltd.
12.1.9. Perrigo Laboratories
India Pvt. Ltd.
12.1.10.
Bayer India Ltd.
13.
Strategic Recommendations
14. About Us & Disclaimer